SCHEMBL7405369

SCHEMBL7405369

N/C(=C\OCc1ccccc1)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.47
MAPK1 P28482 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
PARP10 Q53GL7 1/20 0.45
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
HCAR2 Q8TDS4 1/20 0.43
KMT2A Q03164 2/20 0.43
SLC6A2 P23975 1/20 0.43
SLC6A3 Q01959 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
IDO1 P14902 1/20 0.42
SLC1A3 P43003 2/20 0.41
SLC1A2 P43004 2/20 0.41
SLC1A1 P43005 2/20 0.41
LMNA P02545 2/20 0.41
MEN1 O00255 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7405370 1.00 ALDH1A1 (0.47) ALDH1A1MAPK1L3MBTL1PARP10NPC1
SCHEMBL2808822 0.78 ALDH1A1 (0.53) ALDH1A1MAPK1L3MBTL1NPC1RAB9A
SCHEMBL981849 0.78 ALDH1A1 (0.53) ALDH1A1MAPK1L3MBTL1NPC1RAB9A
Carbamic Acid SCHEMBL28101020 0.77 SLC1A3 (0.47) ALDH1A1MAPK1L3MBTL1PARP10NPC1
SCHEMBL27671120 0.77 ALDH1A1 (0.47) ALDH1A1PARP10NPC1RAB9AHCAR2
SCHEMBL27866145 0.77 PARP10 (0.47) ALDH1A1MAPK1L3MBTL1PARP10NPC1
SCHEMBL28343510 0.76 KMT2A (0.50) ALDH1A1MAPK1L3MBTL1NPC1RAB9A
Oxalic Acid SCHEMBL28207256 0.75 ALDH1A1 (0.53) ALDH1A1MAPK1L3MBTL1NPC1RAB9A
SCHEMBL3463121 0.74 HCAR2 (0.47) ALDH1A1MAPK1L3MBTL1PARP10NPC1
SCHEMBL23580401 0.74 CES1 (0.44) ALDH1A1MAPK1L3MBTL1HCAR2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6468977-B1 COMPOUNDS USEFUL IN TREATMENT TREATMENT OF DISORDER AND/OR DISEASE CAUSED BY ACTIVITY OF ENZYMES SUCH AS HUMAN RHINOVIRUS 3C PROTEASE, TRANSGLUTAMINASE AND CATHEPSINS APOTEX INC. (CA) 2002-10-22 US disclosed
WO-2001090095-A1 THIADIAZOLE COMPOUNDS USEFUL AS INHIBITORS OF CYSTEINE ACTIVITY DEPENDENT ENZYMES APOTEX INC. (CA) 2001-11-29 WO disclosed